RS34010237 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Serum albumin levels | — | β: 0.089 | 2E-40 | PubMed |
| Total protein levels | A | OR: 0.11 | 3E-27 | PubMed |
| Total cholesterol levels | A | β: 0.044 | 5E-26 | PubMed |
| Albumin levels | A | β: 0.074 | 2E-15 | PubMed |
| Type 2 diabetes | G | — | 4E-14 | PubMed |
| Monounsaturated fatty acid levels | A | — | 1E-12 | PubMed |
| Aspartate aminotransferase levels | A | β: 0.031 | 9E-12 | PubMed |
| Monounsaturated fatty acid levels | A | — | 9E-12 | PubMed |
| Total fatty acid levels | A | — | 1E-10 | PubMed |
| Total cholesterol levels | — | β: 0.037 | 6E-10 | PubMed |
| Aspartate aminotransferase levels | — | β: 0.035 | 6E-10 | PubMed |
| Triglyceride levels | A | β: 0.02 | 8E-10 | PubMed |
| Red blood cell count | A | β: 0.029 | 1E-9 | PubMed |
| Monounsaturated fatty acid levels | A | — | 2E-9 | PubMed |
| Saturated fatty acids levels | A | — | 9E-9 | PubMed |
| Omega-6 fatty acid levels | A | — | 9E-9 | PubMed |
| Hematocrit | A | β: 0.026 | 2E-8 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | A | β: 0.077 | 3E-8 | PubMed |
| Total fatty acid levels | A | — | 3E-8 | PubMed |
| Omega-6 fatty acid levels | A | — | 4E-8 | PubMed |